These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Current acute stroke trials and their potential impact on the therapeutic time window. Schellinger PD; Köhrmann M Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672 [TBL] [Abstract][Full Text] [Related]
45. The molecular basis of thrombolysis and its clinical application in stroke. Murray V; Norrving B; Sandercock PA; Terént A; Wardlaw JM; Wester P J Intern Med; 2010 Feb; 267(2):191-208. PubMed ID: 20175866 [TBL] [Abstract][Full Text] [Related]
46. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator. Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117 [TBL] [Abstract][Full Text] [Related]
48. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia. Yang Y; Li Q; Miyashita H; Howlett W; Siddiqui M; Shuaib A J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299 [TBL] [Abstract][Full Text] [Related]
49. [Thrombolytic therapy in acute ischemic stroke: present and future]. Mori E No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978 [No Abstract] [Full Text] [Related]
50. Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy. White CW Circulation; 1989 Nov; 80(5):1482-5. PubMed ID: 2805279 [No Abstract] [Full Text] [Related]
51. The concept of combination therapy in acute ischemic stroke. Sacchetti ML; Toni D; Fiorelli M; Argentino C; Fieschi C Neurology; 1997 Nov; 49(5 Suppl 4):S70-4. PubMed ID: 9371156 [No Abstract] [Full Text] [Related]